Loading…
Loading…
DXCM · NASDAQ · Healthcare
“At thirty-one times earnings, this medical device maker demands exceptional growth sustainability to justify its premium valuation above conservative investment thresholds.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$26.39B
P/E Ratio
31.55
Forward P/E
—
EPS
$2.14
PEG Ratio
0.39
Book Value
$7.04
Dividend Yield
—
Profit Margin
17.94%
ROE
30.46%
Use the interactive ipo calendar with pre-loaded data for Dexcom Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for DXCM: